Published in Medical Letter on the CDC and FDA, June 28th, 2009
The data presented today reviewed the impact of adding Cycloset to the treatment regimen of patients with Type 2 diabetes who...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA